Fig. 4From: Mutational landscape of nasopharyngeal carcinoma based on targeted next-generation sequencing: implications for predicting clinical outcomesKaplan–Meier estimates comparing distant metastasis-free survival of patients with nasopharyngeal carcinoma (NPC). a With and without an altered PI3K-Akt signaling pathway. b With and without an altered Ras signaling pathway. c With and without an altered MAPK signaling pathway. d With and without an altered Rap1 signaling pathwayBack to article page